Off-season RSV epidemics in Australia after easing of COVID-19 restrictions
-
Published:2022-05-24
Issue:1
Volume:13
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Eden John-SebastianORCID, Sikazwe Chisha, Xie Ruopeng, Deng Yi-Mo, Sullivan Sheena G.ORCID, Michie Alice, Levy Avram, Cutmore Elena, Blyth Christopher C., Britton Philip N., Crawford Nigel, Dong Xiaomin, Dwyer Dominic E.ORCID, Edwards Kimberly M.ORCID, Horsburgh Bethany A., Foley DavidORCID, Kennedy Karina, Minney-Smith Cara, Speers David, Tulloch Rachel L., Holmes Edward C.ORCID, Dhanasekaran VijaykrishnaORCID, Smith David W.ORCID, Kok JenORCID, Barr Ian G.ORCID, Alafaci Annette, Carter Ian, Daley Andrew, Francis Michelle, Kesson Alison, Moore Hannah, Ngo Christine, Tran Tyna,
Abstract
AbstractHuman respiratory syncytial virus (RSV) is an important cause of acute respiratory infection with the most severe disease in the young and elderly. Non-pharmaceutical interventions and travel restrictions for controlling COVID-19 have impacted the circulation of most respiratory viruses including RSV globally, particularly in Australia, where during 2020 the normal winter epidemics were notably absent. However, in late 2020, unprecedented widespread RSV outbreaks occurred, beginning in spring, and extending into summer across two widely separated regions of the Australian continent, New South Wales (NSW) and Australian Capital Territory (ACT) in the east, and Western Australia. Through genomic sequencing we reveal a major reduction in RSV genetic diversity following COVID-19 emergence with two genetically distinct RSV-A clades circulating cryptically, likely localised for several months prior to an epidemic surge in cases upon relaxation of COVID-19 control measures. The NSW/ACT clade subsequently spread to the neighbouring state of Victoria and to cause extensive outbreaks and hospitalisations in early 2021. These findings highlight the need for continued surveillance and sequencing of RSV and other respiratory viruses during and after the COVID-19 pandemic, as mitigation measures may disrupt seasonal patterns, causing larger or more severe outbreaks.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference52 articles.
1. Shi, T. et al. Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: A systematic review and meta-analysis. J. Infect. Dis. 222, S577–S583 (2020). 2. Griffiths, C., Drews, S. J. & Marchant, D. J. Respiratory syncytial virus: Infection, detection, and new options for prevention and treatment. Clin. Microbiol. Rev. 30, 277–319 (2017). 3. Fleming, D. M. et al. Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infect. Dis. 15, 443 (2015). 4. Lee, N. et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin. Infect. Dis. 57, 1069–1077 (2013). 5. Li, Y. et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: A systematic analysis. Lancet Glob. Health 7, e1031–e1045 (2019).
Cited by
129 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|